Xponance, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Xponance, Inc. holds 11,265 shares of RARE stock, worth $511,431. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,265

Previous 11,091 1.57%

Holding current value

$511,431

Previous $455,000 37.36%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$40.21 - $59.36 $6,996 - $10,328	174 Added 1.57%	11,265 $625,000
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $47,860 - $66,009	1,279 Added 13.04%	11,091 $455,000
Q1 2024 May 13, 2024	SELL	$43.02 - $53.69 $15,057 - $18,791	-350 Reduced 3.44%	9,812 $458,000
Q4 2023 Jan 31, 2024	BUY	$31.73 - $49.19 $20,561 - $31,875	648 Added 6.81%	10,162 $485,000
Q3 2023 Oct 23, 2023	BUY	$34.92 - $46.66 $1,850 - $2,472	53 Added 0.56%	9,514 $339,000
Q2 2023 Jul 13, 2023	BUY	$37.35 - $52.15 $68,126 - $95,121	1,824 Added 23.88%	9,461 $436,000
Q1 2023 Apr 17, 2023	SELL	$36.99 - $48.71 $2,885 - $3,799	-78 Reduced 1.01%	7,637 $306,000
Q4 2022 Jan 23, 2023	BUY	$33.72 - $46.33 $45,656 - $62,730	1,354 Added 21.29%	7,715 $0
Q3 2022 Oct 24, 2022	SELL	$39.96 - $66.14 $3,396 - $5,621	-85 Reduced 1.32%	6,361 $263,000
Q2 2022 Aug 02, 2022	BUY	$45.8 - $85.4 $34,350 - $64,050	750 Added 13.17%	6,446 $385,000
Q1 2022 Apr 20, 2022	SELL	$62.2 - $84.4 $1,368 - $1,856	-22 Reduced 0.38%	5,696 $414,000
Q4 2021 Jan 31, 2022	BUY	$73.71 - $87.86 $7,149 - $8,522	97 Added 1.73%	5,718 $481,000
Q3 2021 Nov 05, 2021	SELL	$77.92 - $102.4 $13,480 - $17,715	-173 Reduced 2.99%	5,621 $507,000
Q2 2021 Aug 12, 2021	BUY	$92.19 - $115.71 $534,148 - $670,423	5,794 New	5,794 $552,000
Q1 2021 May 10, 2021	SELL	$106.9 - $167.73 $196,482 - $308,287	-1,838 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$84.4 - $177.39 $155,127 - $326,042	1,838 New	1,838 $254,000
Q3 2020 Oct 26, 2020	SELL	$72.98 - $90.0 $191,718 - $236,430	-2,627 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $123,232 - $205,483	2,627 New	2,627 $205,000

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account